AMRYT PHARMA PLC - SPNR ADR (AMYT)

US03217L1061 - ADR

14.7  +0.01 (+0.07%)

After market: 14.7 0 (0%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to AMYT. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 36.48. This target is 148.2% above the current price.
AMYT was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about AMYT.
In the previous month the buy percentage consensus was at a similar level.
AMYT was analyzed by 7 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 14.7036.1336.4836.4837.56 - 145.76% 148.20% 148.20% 155.50%
Up and Down Grades
Date Firm Action Rating
2023-01-18 HC Wainwright & Co. Downgrade Buy -> Neutral
2023-01-10 Cantor Fitzgerald Downgrade Overweight -> Neutral
2023-01-10 Canaccord Genuity Downgrade Buy -> Hold
2023-01-10 Maxim Group Downgrade Buy -> Hold
2023-01-09 SVB Leerink Downgrade Outperform -> Market Perform
2022-06-24 SVB Leerink Maintains Outperform
2022-05-05 SVB Leerink Maintains Outperform
2022-03-10 SVB Leerink Maintains Outperform
2022-03-10 HC Wainwright & Co. Maintains Buy
2021-11-23 SVB Leerink Maintains Outperform
2021-10-04 JonesTrading Initiate Buy
2021-08-19 SVB Leerink Initiate Outperform
2021-07-27 HC Wainwright & Co. Initiate Buy
2021-03-31 Maxim Group Initiate Buy